GILD Stock UPDATES Gilead Sciences (GILD) 96.36 08/14/2014 1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 96.36 $GILD

Final Glance: Biotechnology companies
AP - 2 hrs 46 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:

Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 4:20PM CDT
Amgen (AMGN) suffered a major setback when its phase III study, FOCUS on multiple myeloma treatment, Kyprolis did not meet its primary endpoint.

Gilead Sciences Set to Possibly Pullback After Yesterday's Rally of 2.53%
Comtex SmarTrend(R) - Thu Aug 14, 3:38PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $94.24 to a high of $96.37. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $94.61 on volume of 12.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Midday Glance: Biotechnology companies
AP - Thu Aug 14, 12:16PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:

Should Gilead Sciences (GILD) Be in Your Portfolio? - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Thu Aug 14, 12:00PM CDT
A closer look at Gilead Sciences (GILD) stock and if it should be in your portfolio.

Biotech, Social Media Stocks Are Less Frothy Than Janet Yellen Thinks
at The Street - Thu Aug 14, 11:34AM CDT
A month after Fed Chair Janet Yellen's comments, ETFs covering both groups are pushing towards new highs on strong fundamental backdrops.

Early Glance: Biotechnology companies
AP - Thu Aug 14, 9:33AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:

Stock Market News for August 14, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 9:10AM CDT
Benchmarks ended in the green as gains in biotech stocks offset discouraging retail sales numbers

Gilead Sciences (GILD) Crosses Pivot Point Resistance at $94.61
Comtex SmarTrend(R) - Thu Aug 14, 9:00AM CDT
Shares of Gilead Sciences (NASDAQ:GILD) have bullishly opened above the pivot of $93.98 today and have reached the first resistance level of $94.61. Investors may be interested in a cross of the next upside pivot targets of $95.25 and $96.52.

Zacks.com featured expert Kevin Matras highlights: Gilead Sciences, LyondellBasell, Magna Int'l, RF Micro Devices and United Continental Holdings.
PR Newswire - Thu Aug 14, 8:30AM CDT
Stocks in this week's article include: Gilead Sciences (NASDAQ: GILD - Free Report), LyondellBasell (NYSE: LYB - Free Report), Magna Int'l (NYSE: MGA - Free Report), RF Micro Devices (NASDAQ: RFMD - Free Report) and United Continental Holdings (NYSE: UAL - Free Report). Kevin Matras talks about a stock's Earnings Yield and how to use it.

Strong Earnings Season Winding Down - Earnings Trends
Sheraz Mian - Zacks Investment Research - Thu Aug 14, 2:19AM CDT
Strong Earnings Season Winding Down - Earnings Trends

Strong Earnings Season Winding Down - Earnings Outlook
Sheraz Mian - Zacks Investment Research - Thu Aug 14, 2:19AM CDT
Strong Earnings Season Winding Down - Earnings Outlook

Dendreon Down on Default Risk, Reports Narrower Q2 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 1:37PM CDT
Shares of Dendreon Corporation (DNDN) were down significantly after the company warned that it will not be able to repay or refinance its notes due 2016.

BioDelivery Sciences Q2 Loss Narrows, Up on Solid Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 12:02PM CDT
Shares of BioDelivery Sciences International, Inc. (BDSI) jumped 7.58 % after the company reported its second-quarter 2014 results.

Pharmacyclics Has Edge Over Blood Cancer Competitors
at The Street - Wed Aug 13, 9:49AM CDT
Imbruvica will be an important part of the treatment landscape for blood cancers.

Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 9:40AM CDT
Intercept Pharmaceuticals, Inc. (ICPT) reported earnings of $1.51 per share in the quarter comparing favorably with the Zacks Consensus estimate of a loss of $1.10.

Gilead Sciences,Melco Crown Entertainment,Banco Santander, BarclaysandDeutsche Bankhighlighted as Zacks Bull and Bear of the Day
PR Newswire - Wed Aug 13, 8:30AM CDT
Zacks Equity Research highlights Gilead Sciences (Nasdaq:GILD-Free Report) as the Bull of the Day and Melco Crown Entertainment (Nasdaq:MPEL-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onBanco Santander, S.A. (NYSE:SAN-Free Report), Barclays PLC (NYSE:BCS-Free Report) and Deutsche Bank AG (NYSE B-Free Report).

Celladon (CLDN) Falls: Stock Goes Down 6.2% - Tale of the Tape
Zacks Research Stuff - Zacks Investment Research - Wed Aug 13, 7:30AM CDT
Celladon stock fell over 6% last trading session, continuing its recent downtrend




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dario's Personify Panel Puts Distribution Model in Focus

Updated Category News Views 246

A Partner Megaphone Is Not a Revenue Line Monday's virtual panel gives DarioHealth a useful stage, but investors should not confuse a conference microphone with a signed sales order. Erez Raphael is set to lead a November 23 discussion with Personify Health President Ed Liebowitz at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum, running from noon to 12:50 p.m....

Continue Reading
Fervo IPO Lawsuit Puts 71% Share Collapse in Focus

Updated Category News Views 53

Fervo’s $27 debut has turned into the sort of wreckage IPO buyers dread: shares were alleged to have closed as low as $7.79 when the complaint was filed. That is more than a 71% fall from the May 13, 2026 offering price, and it puts a hard, ugly number beside the new securities class action against the geothermal power developer. More Than a Bad Quarter Is Being Alleged...

Continue Reading
Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 57

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 60

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 73

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 70

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 77

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 125

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 89

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Physician Compensation Management at Southwell

Updated Category News Views 112

Revolutionizing Physician Compensation with Clinician Nexus In a significant move towards streamlining physician compensation processes, Southwell, a notable health system in South Central Georgia, has partnered with Clinician Nexus, a leader in clinical workforce technology. This collaboration will introduce Clinician Nexus’ advanced physician compensation management...

Continue Reading
Transforming a $1000 Investment in Digital Realty Trust Today

Updated Category News Views 208

Long-Term Investing Success with Digital Realty Trust Digital Realty Trust (NYSE: DLR) has shown remarkable performance in the financial markets, surpassing typical market returns consistently over the last two decades. With an impressive annualized return of 11.8%, this company has proven its capability to deliver value to its investors. The Growth of Your Initial...

Continue Reading
Investigation Launched on Markforged Shareholder Deal Fairness

Updated Category News Views 89

So here’s the scoop: Ademi LLP has kicked off an investigation into Markforged Holding Corporation (NYSE: MKFG), and it’s not just for show. The focus? To unpack whether the company’s board is doing their job right in a deal that smells a bit fishy with Nano Dimension. A Stinky Deal Under this agreement, shareholders are looking at a measly $5.00 per share—sounds...

Continue Reading
Introducing Noel Ortega: A Transformative Leader at SAFCO

Updated Category News Views 179

SAFCO Welcomes New Leadership in Account Services Southern Auto Finance Company, LLC (SAFCO) is thrilled to announce that Noel Ortega has been appointed as the new Senior Vice President of Account Services. Mr. Ortega comes with a wealth of knowledge from over 20 years in the auto finance sector, emphasizing collections and outstanding customer service. Mr. Ortega's...

Continue Reading
BBG Expands Services with New Data Center Specialty Practice

Updated Category News Views 167

BBG Unveils New Data Center Specialty Practice BBG, a prominent figure in the national commercial real estate services arena, has recently launched a dedicated Data Center Specialty Practice to address the surging demand for valuation and advisory services within the mission-critical infrastructure domain. Leading the charge is Christopher M. Fudacz, a seasoned expert in...

Continue Reading